Hims & Hers Health disclosed a transaction with the SEC, while Director David Wells acquired stock and TD Cowen covered the stock.
1 report, 1 independent
Updated May 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Hims & Hers Health disclosed a transaction with the SEC, while Director David Wells acquired stock and TD Cowen covered the stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Hims & Hers Health
American telehealth company
Nothing else this week.
-
SEC
Slovak company
-
TD Cowen
American investment bank
Related events
- HCW Biologics Inc. filed disclosures with the SEC and its shares are listed on Nasdaq.
- LuxExperience disclosed a stock transaction in an SEC filing on October 8, 2026.
- Capricor Therapeutics disclosed insider trading filings with the SEC and was listed on the Nasdaq stock exchange.
- HEICO disclosed an acquisition in an SEC filing.
- SoFi disclosed insider trades via an SEC filing on October 19, 2026.